Towards individualized therapy for metastatic renal cell carcinoma

RR Kotecha, RJ Motzer, MH Voss - Nature reviews Clinical oncology, 2019 - nature.com
Over the past decade, the treatment landscape for patients with metastatic renal cell
carcinoma (RCC) has evolved dramatically. The therapeutic options available have …

Familial kidney cancer: implications of new syndromes and molecular insights

MI Carlo, AA Hakimi, GD Stewart, G Bratslavsky… - European urology, 2019 - Elsevier
Context Hereditary cases account for about 5% of all cases of renal cell carcinoma (RCC).
With advances in next-generation sequencing, several new hereditary syndromes have …

Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma

MI Carlo, S Mukherjee, D Mandelker, J Vijai… - JAMA …, 2018 - jamanetwork.com
Importance Identification of patients with hereditary renal cell carcinoma (RCC) is important
for cancer screening and, in patients with advanced disease, for guiding treatment. The …

Universal germline genetic testing for hereditary cancer syndromes in patients with solid tumor cancer

ED Esplin, SM Nielsen, SL Bristow, JE Garber… - JCO Precision …, 2022 - ascopubs.org
Historically, professional society guidelines have recommended limited genetic testing for
hereditary cancer syndromes (HCS) to patients with cancer thought to be at highest risk for …

Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement

G Bratslavsky, N Mendhiratta, M Daneshvar… - Cancer, 2021 - Wiley Online Library
Background Although renal cell carcinoma (RCC) is believed to have a strong hereditary
component, there is a paucity of published guidelines for genetic risk assessment. A panel of …

Cytoreductive surgery, systemic treatment, genetic evaluation, and patient perspective in a young adult with metastatic renal cell carcinoma

EH Nicaise, A Yildirim, S Sheth… - CA: A Cancer …, 2024 - Wiley Online Library
A man aged 41 years who had a past medical history significant for bilateral lower extremity
varicosities and a prior 20‐pack‐year smoking history reported several days of fatigue to his …

Artificial neural networks as a way to predict future kidney cancer incidence in the United States

M Santoni, F Piva, C Porta, S Bracarda… - Clinical Genitourinary …, 2021 - Elsevier
Introduction The incidence of kidney cancer is increasing; it could be counteracted with new
ways to predict and detect it. We aimed to implement an artificial neural network in order to …

Clinical and molecular characterization of microphthalmia-associated transcription factor (MITF)-related renal cell carcinoma

M Lang, CD Vocke, CJ Ricketts, AR Metwalli, MW Ball… - Urology, 2021 - Elsevier
Objectives To characterize the clinical presentation, genomic alterations, pathologic
phenotype and clinical management of microphthalmia-associated transcription factor …

Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases

B Yngvadottir, A Andreou… - Human Molecular …, 2022 - academic.oup.com
Renal cell carcinoma (RCC) occurs in a number of cancer predisposition syndromes, but the
genetic architecture of susceptibility to RCC is not well defined. We investigated the …

Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing

H Truong, R Sheikh, R Kotecha, Y Kemel… - European urology …, 2021 - Elsevier
Background Despite guidelines recommending genetic counseling for patients with early-
onset renal cell carcinoma (RCC), studies interrogating the spectrum of germline mutations …